The Wegovy pill is not the only option at Hims & Hers, but the platform promotes it as the default first recommendation
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
For advisors seeking a broader medical perspective, the Tema Heart & Health ETF (HRTS) positions the weight loss trend within a larger cardiology and metabolic diseases framework
The Synergistic Approach Synergistic approach means using two or more treatments simultaneously to achieve superior results than either alone
Track cycles, pain scores, and daily function to allow clinicians to fine-tune treatment
In fact, liraglutide is sold under a different brand name, Saxenda, as an FDA-approved weight loss drug